Moxetumomab Pasudotox-tdfk and Zoladex (Goserelin Implant 10.8 mg)
Determining the interaction of Moxetumomab Pasudotox-tdfk and Zoladex (Goserelin Implant 10.8 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Zoladex (Goserelin Implant 3.6 mg)
- Moxetumomab Pasudotox-tdfk-Zoladex 3-Month
- Moxetumomab Pasudotox-tdfk-Zoladex Implant
- Moxetumomab Pasudotox-tdfk-Zolate
- Moxetumomab Pasudotox-tdfk-Zoledronic acid
- Moxetumomab Pasudotox-tdfk-Zoledronic Acid (Bone Health)
- Zoladex (Goserelin Implant 10.8 mg)-Moxetumomab pasudotox-tdfk Intravenous
- Zoladex (Goserelin Implant 10.8 mg)-Moxifloxacin
- Zoladex (Goserelin Implant 10.8 mg)-Moxifloxacin (Systemic)
- Zoladex (Goserelin Implant 10.8 mg)-Moxifloxacin Hydrochloride
- Zoladex (Goserelin Implant 10.8 mg)-Moxifloxacin Injection
- Zoladex (Goserelin Implant 10.8 mg)-Moxifloxacin Intravenous